According to Veracyte's latest financial reports and stock price the company's current number of shares outstanding is 72,804,770. At the end of 2023 the company had 72,804,770 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 72.8 M | 1.36% |
2022 | 71.82 M | 1.07% |
2021 | 71.06 M | 22.47% |
2020 | 58.02 M | 18.18% |
2019 | 49.09 M | 20.54% |
2018 | 40.73 M | 19.6% |
2017 | 34.05 M | 7.41% |
2016 | 31.7 M | 14.57% |
2015 | 27.67 M | 22.95% |
2014 | 22.5 M | 61.42% |
2013 | 13.94 M | -1.77% |
2012 | 14.19 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Exact Sciences EXAS | 180,649,000 | 148.13% | ๐บ๐ธ USA |
Myriad Genetics MYGN | 81,900,000 | 12.49% | ๐บ๐ธ USA |
Biocept
BIOC | 1,036,529 | -98.58% | ๐บ๐ธ USA |